|Bid||20.55 x 1000|
|Ask||20.96 x 1400|
|Day's Range||20.68 - 21.75|
|52 Week Range||16.19 - 53.46|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||35.00|
MENLO PARK, Calif., July 21, 2021--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its second quarter 2021 financial results after the market closes on Wednesday, August 4, 2021. In conjunction with the release, the Company will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.
MENLO PARK, Calif., Jun 22, 2021--Personalis Announces NeXT Level Biomarkers Symposium
Personalis, Inc. ( NASDAQ:PSNL ) shareholders might be concerned after seeing the share price drop 14% in the last...